4
Changes in Ownership
GeneDx Holdings Corp. Filed Acc 0001689575-25-000015
CHIEF EXECUTIVE OFFICER sold 3,639 shares at $159.28 ($579,620)
- CHIEF EXECUTIVE OFFICER acquired 6,547 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2025-12-09 | Option exercise | +6,547 | 9,983 | D | ||
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2025-12-09 | Sale | −3,639 | $159.28 | $579,620 | 6,344 | D |
| Derivatives | |||||||
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2025-12-09 | Option exercise · Restricted Stock Unit | −6,547 | 26,186 | D | ||
| Open-market sales · 3,639 sh · avg $159.28 · $579,620 | |||||||
Loading xslF345X05/form4-12112025_091209.xml…